Apple Inc.

Every fourth smartphone sold in China in October was an iPhone, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-11-18/apple-s-iphone-sales-surge-in-china-to-take-25-market-share">writes,</a> citing data from the analytical company Counterpoint Research. Apple's share of the Chinese market reached 25% for the first time since 2022.

Apple's share in China reached 25% for the first time since 2022 thanks to iPhone 17 sales

BYD Company Limited

Agricultural Bank of China Limited

ICBC

Geely Automobile Holdings Limited

Zhejiang Leapmotor Technology Co., Ltd.

The Chinese economy, which never tires of impressing with its achievements in a number of technological sectors, is actually standing on the edge of a dangerous precipice: it is slipping into a deflationary spiral. What is the danger?

China's deflationary trap: which companies and industries will fall into it? 

Shiseido Company, Limited

Pan Pacific International Holdings Corporation

Trip.com Group Limited

The risk of a boycott of Japanese goods in China could hit sales of Uniqlo, Asics and Muji

China has warned the public against traveling to Japan. Which stocks are affected?

Sales of iPhones in China grew by 22% in October - the first month after the release of the iPhone 17 lineup - compared to the same period last year, Reuters <a href="https://www.reuters.com/world/china/apples-china-iphone-sales-jumped-22-month-after-iphone-17-launch-2025-11-14/">writes,</a> citing data from research company Counterpoint. This happened despite the general weakening of the smartphone market in the country, the agency notes.

iPhone sales in China up 22% after the release of the new lineup

Burberry Group plc

Sales in the region that includes China rose 3% after falling 5%

Burberry reported sales growth in China. Is everything so rosy in this market?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Akeso, Inc.

Legend Biotech Corporation

3SBIO

BeOne Medicines AG

INNOVENT BIO

In 2025, biotech companies from China are likely to renew the record for the sixth consecutive year in terms of the volume of deals with Western pharma giants actively buying up the rights to develop and sell Chinese drugs. Ilya Zubkov, Freedom Broker's senior analyst for the healthcare sector, has selected seven companies that investors looking to capitalize on the growth of Chinese biotech should pay attention to.

China's biotech companies are booming. How to capitalize on it? 

LVMH Moet Hennessy - Louis Vuitton, Societe Europeenne

Last year, sales of luxury goods in the Chinese market fell by nearly 20 percent

LVMH is preparing a major boutique opening in China. Is the demand for luxury returning?

The emerging markets investment guru predicts a downturn in the artificial intelligence market and advises looking toward China and other Asian countries

Stocks could fall 30-40%, says Mark Mobius. Why is he waiting for the AI bubble to collapse?

Wingtech Technology Co.,Ltd

The U.S. Senate has approved the first phase of a deal to end the shutdown. Shares of Wingtech Technology - Nexperia's parent company - jumped after China and the Netherlands agreed to talks to lift restrictions on supplying chips to automakers. On these and other topics - in our review of key events for the morning of November 10.

Sibanye Stillwater Limited

Lynas Rare Earths Limited

Range Resources Corporation

Active negotiations between the US and China, sanctions policy and the US shutdown determine the composition of the portfolio in November. Alexander Orlov, Managing Director of Arbat Capital, proposed a strategy that balances both investors' expectations and the results of specific companies.

Where to invest $10,000 in November: Between America and China

Tesla, Inc.

NVIDIA Corporation

Tesla shareholders have approved a near $1 trillion payout package for Elon Musk, who has promised to turn the company into an AI and robotics giant and said he plans to build his own chip factory "times the size of a gigafactory." Japan's SoftBank has lost over $50 billion in capitalization amid a collapse in AI stocks and growing doubts about overheated valuations. On these and other topics - in our review of key events by the morning of November 7.

Highlights for this morning: Musk's AI race, Nvidia chip ban, OpenAI 'proxy' under pressure

Advanced Micro Devices, Inc.

Intel Corporation

Chinese authorities have invested at least $100 billion in data center construction since 2021